(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
3 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 7.61%
@ $7.87
Išleistas: 21 kov. 2024 @ 20:10
Grąža: -18.43%
Ankstesnis signalas: kov. 21 - 19:13
Ankstesnis signalas:
Grąža: -0.76 %
Live Chart Being Loaded With Signals
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 5.46M |
Vidutinė apimtis | 5.53M |
Rinkos kapitalizacija | 1.49B |
EPS | $0 ( 2024-02-22 ) |
Kita pelno data | ( $-0.130 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -21.40 |
ATR14 | $0.0100 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Raab Michael | Sell | 7 500 | Common Stock |
2024-04-01 | Raab Michael | Sell | 1 518 | Common Stock |
2024-03-25 | Kelliher Mike | Buy | 205 000 | Stock Option (Right to Buy) |
2024-03-25 | Kelliher Mike | Buy | 160 000 | Common Stock |
2024-03-25 | Kelliher Mike | Buy | 0 |
INSIDER POWER |
---|
66.46 |
Last 99 transactions |
Buy: 4 000 095 | Sell: 852 364 |
Tūris Koreliacija
Ardelyx Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
MLAI | 0.964 |
KAII | 0.959 |
FRSG | 0.959 |
TCMD | 0.956 |
ACQR | 0.954 |
NVSA | 0.952 |
GLLI | 0.952 |
ARRW | 0.952 |
TBSA | 0.951 |
CPAQ | 0.95 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
CSSEP | -0.96 |
EQBK | -0.957 |
FCBC | -0.951 |
MBOT | -0.949 |
DRUG | -0.945 |
BMRA | -0.944 |
EVLO | -0.942 |
FSFG | -0.942 |
SPFI | -0.941 |
BWB | -0.94 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Ardelyx Inc Koreliacija - Valiuta/Žaliavos
Ardelyx Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $124.46M |
Bruto pelnas: | $106.66M (85.70 %) |
EPS: | $-0.300 |
FY | 2023 |
Pajamos: | $124.46M |
Bruto pelnas: | $106.66M (85.70 %) |
EPS: | $-0.300 |
FY | 2022 |
Pajamos: | $52.16M |
Bruto pelnas: | $48.04M (92.11 %) |
EPS: | $-0.420 |
FY | 2021 |
Pajamos: | $10.10M |
Bruto pelnas: | $9.10M (90.10 %) |
EPS: | $-1.520 |
Financial Reports:
No articles found.
Ardelyx Inc
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.